EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF LISINOPRIL COMPARED TO ATENOLOL IN BLACK, MIXED, AND INDIAN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION

被引：0
作者：
SEEDAT, YK
VERIAVA, Y
COHEN, JD
DATELING, F
MILNE, JF
PARAG, KB
机构：
[1] KING EDWARD VIII HOSP,DEPT MED,DURBAN,SOUTH AFRICA
[2] CORONATION HOSP,DEPT MED,JOHANNESBURG,SOUTH AFRICA
[3] UNIV WITWATERSRAND,JOHANNESBURG 2001,SOUTH AFRICA
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1987年 / 41卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：852 / 864
页数：13
相关论文
共 10 条
[1]   EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].
BRUNNER, DB ;
DESPONDS, G ;
BIOLLAZ, J ;
KELLER, I ;
FERBER, F ;
GAVRAS, H ;
BRUNNER, HR ;
SCHELLING, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467
[2]  
BUSSIEN JP, 1985, CURR THER RES CLIN E, V37, P342
[3]   ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL [J].
CHRYSANT, SG ;
BROWN, RD ;
KEM, DC ;
BROWN, JL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :741-746
[4]  
GOODMAN C, 1985, S AFR MED J, V27, P1672
[5]   ENALAPRIL (MK421) AND ITS LYSINE ANALOG (MK521) - A COMPARISON OF ACUTE AND CHRONIC EFFECTS ON BLOOD-PRESSURE, RENINANGIOTENSIN SYSTEM AND SODIUM-EXCRETION IN NORMAL MAN [J].
HODSMAN, GP ;
ZABLUDOWSKI, JR ;
ZOCCALI, C ;
FRASER, R ;
MORTON, JJ ;
MURRAY, GD ;
ROBERTSON, JIS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (03) :233-241
[6]   PHARMACODYNAMICS OF CONVERTING ENZYME-INHIBITION - THE CARDIOVASCULAR, ENDOCRINE AND AUTONOMIC EFFECTS OF MK421 (ENALAPRIL) AND MK521 [J].
MILLAR, JA ;
DERKX, FHM ;
MCLEAN, K ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :347-355
[7]   RESPONSES TO CAPTOPRIL AND HYDROCHLOROTHIAZIDE IN BLACK PATIENTS WITH HYPERTENSION [J].
MOSER, M ;
LUNN, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) :307-312
[8]   ANTIHYPERTENSIVE EFFICACY OF ONCE DAILY MK-521, A NEW NONSULFHYDRYL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].
ROTMENSCH, HH ;
VLASSES, PH ;
SWANSON, BN ;
IRVIN, JD ;
HARRIS, KE ;
MERRILL, DG ;
FERGUSON, RK .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (01) :116-119
[9]  
SEEDAT YK, 1987, S AFR MED J, V71, P149
[10]   ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) - DISPOSITION IN MAN [J].
ULM, EH ;
HICHENS, M ;
GOMEZ, HJ ;
TILL, AE ;
HAND, E ;
VASSIL, TC ;
BIOLLAZ, J ;
BRUNNER, HR ;
SCHELLING, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :357-362
1